» Articles » PMID: 33335909

Exploring the Impact of Obesity on Skeletal Muscle Function in Older Age

Overview
Journal Front Nutr
Date 2020 Dec 18
PMID 33335909
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Sarcopenia is of important clinical relevance for loss of independence in older adults. The prevalence of obesity in combination with sarcopenia ("sarcopenic-obesity") is increasing at a rapid rate. However, whilst the development of sarcopenia is understood to be multi-factorial and harmful to health, the role of obesity from a protective and damaging perspective on skeletal muscle in aging, is poorly understood. Specifically, the presence of obesity in older age may be accompanied by a greater volume of skeletal muscle mass in weight-bearing muscles compared with lean older individuals, despite impaired physical function and resistance to anabolic stimuli. Collectively, these findings support a potential in which obesity may protect skeletal muscle mass in older age. One explanation for these paradoxical findings may be that the anabolic response to weight-bearing activity could be greater in obese vs. lean older individuals due to a larger mechanical stimulus, compensating for the heightened muscle anabolic resistance. However, it is likely that there is a complex interplay between muscle, adipose, and external influences in the aging process that are ultimately harmful to health in the long-term. This narrative briefly explores of the potential mechanisms regulating changes in skeletal muscle mass and function in aging combined with obesity and the interplay with sarcopenia, with a particular focus on muscle morphology and the regulation of muscle proteostasis. In addition, whilst highly complex, we attempt to provide an updated summary for the role of obesity from a protective and damaging perspective on muscle mass and function in older age. We conclude with a brief discussion on treatment of sarcopenia and obesity and a summary of future directions for this research field.

Citing Articles

The role of autoantibodies in bridging obesity, aging, and immunosenescence.

Valentino T, Chen N, Makhijani P, Khan S, Winer S, Revelo X Immun Ageing. 2024; 21(1):85.

PMID: 39616399 PMC: 11607830. DOI: 10.1186/s12979-024-00489-2.


Can simple measures from clinical practice serve as a proxy for sarcopenic obesity and identify mortality risk?.

Guandalini V, Tofani P, Souza Lima S, Coelho Silveira L, Cochar-Soares N, Barros Pereira da Silva T Aging Clin Exp Res. 2024; 36(1):222.

PMID: 39557762 PMC: 11573834. DOI: 10.1007/s40520-024-02866-9.


Association between dynapenic obesity phenotypes and physical performance in middle-age and older women living in community.

Arteaga-Pazmino C, Fonseca-Perez D, Balladares Mazzini M, Galvez-Celi J, Emen Sanchez J, Alvarez-Cordova L Front Nutr. 2024; 11:1480284.

PMID: 39385775 PMC: 11461314. DOI: 10.3389/fnut.2024.1480284.


Associations between physical fitness, body composition, and heart rate variability during exercise in older people: exploring mediating factors.

Mabe-Castro D, Castillo-Aguilar M, Mabe-Castro M, Mendez Munoz R, Basualto-Alarcon C, Nunez-Espinosa C PeerJ. 2024; 12:e18061.

PMID: 39346081 PMC: 11439397. DOI: 10.7717/peerj.18061.


Daily Physical Activity Does Not Contribute to Differences in Muscle Oxidative Capacity Between Overweight and Obesity.

Simon A, Derella C, Looney J, Norland K, Wang X, Harris R Endocrinol Diabetes Metab. 2024; 7(5):e513.

PMID: 39141578 PMC: 11324093. DOI: 10.1002/edm2.513.


References
1.
Bouchonville M, Villareal D . Sarcopenic obesity: how do we treat it?. Curr Opin Endocrinol Diabetes Obes. 2013; 20(5):412-9. PMC: 4046899. DOI: 10.1097/01.med.0000433071.11466.7f. View

2.
Stephens F, Chee C, Wall B, Murton A, Shannon C, van Loon L . Lipid-induced insulin resistance is associated with an impaired skeletal muscle protein synthetic response to amino acid ingestion in healthy young men. Diabetes. 2014; 64(5):1615-20. DOI: 10.2337/db14-0961. View

3.
Cheung W, Mao P . Recent advances in obesity: genetics and beyond. ISRN Endocrinol. 2012; 2012:536905. PMC: 3313574. DOI: 10.5402/2012/536905. View

4.
Breen L, Stokes K, Churchward-Venne T, Moore D, Baker S, Smith K . Two weeks of reduced activity decreases leg lean mass and induces "anabolic resistance" of myofibrillar protein synthesis in healthy elderly. J Clin Endocrinol Metab. 2013; 98(6):2604-12. DOI: 10.1210/jc.2013-1502. View

5.
Atherton P, Etheridge T, W Watt P, Wilkinson D, Selby A, Rankin D . Muscle full effect after oral protein: time-dependent concordance and discordance between human muscle protein synthesis and mTORC1 signaling. Am J Clin Nutr. 2010; 92(5):1080-8. DOI: 10.3945/ajcn.2010.29819. View